Eris Lifesciences Limited
NSE: ERIS · Healthcare
₹1,309.60
-16.00 (-1.21%)
Last close · 30 Aug 2026, 11:12 am IST
- Open
- ₹1,325.10
- Day high
- ₹1,326.70
- Day low
- ₹1,306.70
- Volume
- 59.5 K
- Prev close
- ₹1,325.60
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 19,409 Cr
- Price
- 1,400.60
- P/E (TTM)
- 30.96
- P/E (Fwd)
- 22.91
- P/B
- 4.91
- EV/EBITDA
- 19.13
- EV/Revenue
- 6.88
- PEG
- —
- Div Yield
- 1.03%
- 52W High
- 1,885.00
- 52W Low
- 1,200.00
- Beta
- -0.11
Profitability & income
- Revenue (TTM)
- 3,115 Cr
- Net Income (TTM)
- 620 Cr
- EBITDA
- 1,120 Cr
- Gross Margin
- 74.46%
- Op. Margin
- 27.12%
- Net Margin
- 19.89%
- ROE
- 18.07%
- ROA
- 7.30%
- EPS (TTM)
- 45.24
- EPS (Fwd)
- 61.14
Financial health
- Total Debt
- 2,359 Cr
- Total Cash
- 67 Cr
- Debt/Equity
- 60.55
- Current Ratio
- 0.74
- Quick Ratio
- 0.36
- Book Value
- 285.48
- Free Cash Flow
- -30 Cr
- Op. Cash Flow
- 538 Cr
Growth
- Revenue Growth
- 7.10%
- Earnings Growth
- 200.00%
- Earnings QoQ
- 201.30%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 752 Cr | 282 Cr | 275 Cr | 204 Cr | 567 Cr | — | 2,359 Cr | 3,903 Cr |
| 2025-12-31 | 801 Cr | 100 Cr | 265 Cr | 211 Cr | 578 Cr | — | — | — |
| 2025-09-30 | 790 Cr | 120 Cr | 291 Cr | 219 Cr | 588 Cr | — | 2,389 Cr | 3,091 Cr |
| 2025-06-30 | 772 Cr | 118 Cr | 280 Cr | 206 Cr | 587 Cr | — | — | — |
| 2025-03-31 | 703 Cr | 94 Cr | 260 Cr | 175 Cr | 532 Cr | — | 2,478 Cr | 2,854 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3,115 Cr | 620 Cr | 1,111 Cr | 841 Cr | 2,319 Cr | 538 Cr | 2,359 Cr | 3,903 Cr |
| 2025-03-31 | 2,879 Cr | 352 Cr | 1,036 Cr | 702 Cr | 2,165 Cr | 1,065 Cr | 2,478 Cr | 2,854 Cr |
| 2024-03-31 | 1,991 Cr | 392 Cr | 699 Cr | 495 Cr | 1,604 Cr | 486 Cr | 2,781 Cr | 2,586 Cr |
| 2023-03-31 | 1,662 Cr | 382 Cr | 548 Cr | 422 Cr | 1,305 Cr | 292 Cr | 877 Cr | 2,196 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for ERIS?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in